Invesco Ltd. Cidara Therapeutics, Inc. Transaction History

Invesco Ltd.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$0.77 - $1.16 $13,249 - $19,960	17,207 Added 68.78%	42,223 $39,000
Q2 2023 Aug 11, 2023	BUY	$1.01 - $1.42 $25,266 - $35,522	25,016 New	25,016 $28,000
Q2 2021 Aug 17, 2021	SELL	$1.87 - $2.7 $53,504 - $77,252	-28,612 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$2.06 - $3.01 $2,175 - $3,178	1,056 Added 3.83%	28,612 $76,000
Q4 2020 Feb 16, 2021	BUY	$1.99 - $3.25 $54,836 - $89,557	27,556 New	27,556 $55,000

Q1 2019 May 15, 2019	SELL	$2.35 - $3.27 $355,721 - $494,983	-151,371 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$2.1 - $4.5 $317,879 - $681,169	151,371 New	151,371 $356,000

22.1M

2.7K

100

Ticker CDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,075,696
Market Cap $889M
Description
Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.